研究

研究室

准教授:酒井 良子(サカイ リョウコ)

研究室

公衆衛生・疫学研究室

最終学歴

東京医科歯科大学大学院医歯学総合研究科博士過程

学位

博士(医学)、公衆衛生学修士(MPH)

講義科目

衛生科学II、海外医療研修コース特論・演習、食品と環境実習

専門分野

薬剤疫学、公衆衛生

研究課題

リウマチ性疾患および他疾患領域における薬剤疫学研究

所属学会

日本リウマチ学会、日本薬剤疫学会、日本社会薬会、日本薬学会

学会活動

日本リウマチ学会評議員、日本リウマチ学会疫学小委員会、日本リウマチ学会臨床研究推進小委員会、日本社会薬学会編集委員

研究業績1

Sakai R, Honda S, Tanaka E, Majima M, Konda N, Takada H, Harigai M.The risk of hospitalized infection in patients with systemic lupus erythematosus treated with hydroxychloroquine. Lupus 29(13) 1712-1718 Nov; 2020

研究業績2

Nakajima A, Sakai R, Inoue E, Harigai M. Prevalence of patients with rheumatoid arthritis and age-stratified trends in clinical characteristics and treatment, based on the National Database of Health Insurance Claims and Specific Health Checkups of Japan. Int R Rheum Dis. 2020 Oct accepted

研究業績3

Sakai R, Cho SK, Jang EJ, Harigai M, Sung YK. International descriptive study for comparison of treatment patterns in patients with knee osteoarthritis between Korea and Japan using claims data. Int J Rheum Dis. 2019 Nov;22 (11):2052-8

研究業績4

Sakai R, Tanaka E, Nishina H, Suzuki M, Yamanaka H, Harigai M. Risk of opportunistic infection in patients with antineutrophil cytoplasmic antibody-associated vasculitis, using a Japanese health insurance database. Int J Rheum Dis. 2019 Nov;22 (11):1978-84

研究業績5

Kasai S, Sakai R, Koike R, Kohsaka H, Miyasaka N, Harigai M. Higher risk of hospitalized infection, cardiovascular disease, and fracture in patients with rheumatoid arthritis determined using the Japanese health insurance database. Mod Rheumatol 2019 Sep;29 (5):788-94

研究業績6

Sakai R, Kasai S, Hirano F, Harada S, Kihara M, Yokoyama W, Tsutsumino M, Nagasaka K, Koike R, Yamanaka H, Miyasaka N, Harigai M. No increased risk of herpes zoster in TNF inhibitor and non-TNF inhibitor users with rheumatoid arthritis: epidemiological study using the Japanese health insurance database. Int J Rheum Dis. 2018 Sep;21(9):1670-7

研究業績7

Harada S, Sakai R, Hirano F, Miyasaka N, Harigai M; REAL Study Group. Association between medications and herpes zoster in Japanese patients with rheumatoid arthritis:A 5-year prospective cohort study. J Rheumatology. 2017 Jul;44(7):988-95

研究業績8

Sakai R, Hirano F, Kihara M, Yokoyama W, Yamazaki H, Harada S, Nanki T, Koike R, Miyasaka N, Harigai M. High prevalence of cardiovascular comorbidities in patients with rheumatoid arthritis from a population-based cross-sectional study of a Japanese health insurance database. Mod Rheumatol. 2016 Jul;26 (4):522-8

研究業績9

Sakai R, Cho SK, Nanki T, Watanabe K, Yamazaki H, Tanaka M, Koike R, Tanaka Y, Saito K, Hirata S, Amano K, Nagasawa H, Sumida T, Hayashi T, Sugihara T, Dobashi H, Yasuda S, Sawada T, Ezawa K, Ueda A, Fujii T, Migita K, Miyasaka N, Harigai M, REAL Study Group: Head to head comparison of the safety of tocilizumab and tumor necrosis factor inhibitors in rheumatoid arthritis (RA) in clinical practice: results from the registry of Japanese RA patients on biologics for long term-safety (REAL) registry. Arthritis Res Ther. 2015 Mar 23;17:74.

研究業績10

Sakai R, Cho SK, Nanki T, Koike R, Watanabe K, Yamazaki H, Nagasawa H, Amano K, Tanaka Y, Sumida T, Ihata A, Yasuda S, Nakajima A, Sugihara T, Tamura N, Fujii T, Dobashi H, Miura Y, Miyasaka N, Harigai M; REAL Study Group: The risk of serious infection in patients with rheumatoid arthritis treated with tumor necrosis factor inhibitors decreased over time: a report from the registry of Japanese rheumatoid arthritis patients on biologics for long-term safety (REAL) database. Rheumatol Int. 2014 Dec; 34 (12):1729-36